Large Quantity Of Laboratory Stem Cells Produced From Small Number Of Blood Stem Cells


Large Quantity Of Laboratory Stem Cells Produced From Small Number Of Blood Stem Cells
A team from the Institute for Research in Immunology and Cancer (IRIC), University of Montreal has managed to produce a large quantity of laboratory stem cells from a small number of blood stem cells obtained from bone marrow.

The multidisciplinary team headed by Dr.Guy Sauvageau did so a giant step towards the development of a revolutionary treatment using stem cells. This world premiere will advance research on stem cells and could have important implications in several areas for which there is currently no treatment.

Each year in North America, nearly four thousand people waiting in vain for a bone marrow transplant due to lack of compatible donor. We know that stem cell transplantation of bone marrow can be used to reconstitute the bone marrow recipient. The main difficulty is to obtain a sufficient number of stem cells compatible. Thanks to Dr. Sauvageau and his team a few years, these patients may get a new bone marrow.

"This could include grafting all adults from the existing banks of umbilical cord blood, including stem cell content is currently limiting the widespread use in adults," says Dr. Sauvageau.

Organ transplants without side effects: the medicine of the future?
Currently, transplant recipients are condemned to take medication against rejection of the transplanted organ to suffer side effects throughout their lives. However,

"There are studies in mice showing that stem cells from bone marrow can prevent rejection typically directed against solid organs," says Dr. Sauvageau.

Rejection occurs because the immune cells, produced by the bone marrow, attack the transplanted organ as if it were an invader. By extrapolation from laboratory studies, it is likely that grafting of hematopoietic stem cells taken from the donor organ and developed in the laboratory would prevent rejection of organ. Hence the importance of having large amounts of hematopoietic stem cells thereby is able to combine stem cells compatible with the organ transplant.

Proteins multiplying stem cells
To produce large quantities of hematopoietic stem cells in the laboratory, the team of Dr. Sauvageau has identified ten proteins from seven hundred candidates. These ten proteins are naturally present within the hematopoietic stem cells. And researchers can use each to force these cells to multiply in the laboratory.

"The next step is to verify if this also works in humans. And everything is already in place “Guy Sauvageau resumed.

These tests will be conducted at the Maisonneuve-Rosemont in Montreal, one of the leading centres in the country where stem cells transplants are performed.

"If one of the ten proteins can increase hematopoietic stem cells in humans, then we can obtain the quantities of cells needed to perform transplants. And then it will be "mission accomplished.”

Many researchers around the world are now trying to harness the regenerative power of other types of stem cells to treat diseases like Alzheimer's or diabetes. The research team IRIC could also help them reach their goal.

The work of the team of Dr. Sauvageau has been funded by the Canadian Institutes for Health Research of Canada and the results are published in the prestigious scientific journal Cell dated April 17. (Reference below)
--
Reference:
Article: A Functional Screen to Identify Novel Effectors of Hematopoietic Stem Cell Activity
Journal Publication: Cell

A PROTEIN TO THE REGENERATION OF THE KIDNEY

|

A Protein To The Regeneration Of The Kidney
Spain - A team from the Spanish Research Network failure (REDinREN) was able to establish why the kidney is able to grow significantly to offset the loss of another kidney, due to illness, accident or of organ donation.

The team of Dr. Ortiz de Jimenez Diaz Foundation in Madrid has seen, in mice, only 2 to 4 hours after removal of both kidneys, a receptor on the cell surface of the remaining kidney and Tweak protein coupled receptor that is growing.

Tests on mice genetically modified to lack the protein Tweak, indicate a virtual absence of the phenomenon of growth of the kidney remaining after removal of the other. If we inject these animals the missing protein, growth returns to normal kidney.

REDinREN was therefore associated with U.S. companies producing Tweak for tests on human patients. In the case of ablation, the remaining kidney would grow easier. In the case of damage to a kidney regeneration it would be easier.

If Tweak promotes the proliferation of kidney cells, it also accelerates the development of tumor cells. The development of antibodies will be necessary for the development of a treatment or even the creation of kidneys in vitro from stem cells.

THE INFERTILE OBESE WOMAN EXPLAINED ?

|

The Infertile Obese Women Explained ?
Australia - Dr Robk University of Adelaide have found the reason for infertility in obese women.

By studying cases of ninety-six women seeking assistance for reproduction in a private clinic between February 2006 and April 2007, Dr. Robk could target an alteration of the ovaries in obese patients, tainting their eggs are unable to into embryos.

Obese women, even young and with regular menstrual cycles, take longer to conceive. Dr. Robk wanted to understand whether environmental degradation of the egg can contribute. His study found that "obese women have a high fat and inflammation in the fluid surrounding the egg, which may affect the development of the latter".

These are fats that alter the egg and are therefore harmful to its development. Inflammation would also jeopardize the survival of the embryo formed. These findings were confirmed by measurements of levels of hormones and metabolites content in the follicular fluid of ovarian cancer patients (accumulation of cells in the ovaries).

Dr. Robk concluded: "Obesity is known to change the fat into the bloodstream and cause inflammation that affects the overall health of a person". Our research shows that obesity is also changing the environment of the ovary which nourishes the developing ova.

STIMULATION OF OVULATION DO NOT INCREASE CANCER RISK

|

Stimulators Of Ovulation Do Not Increase Cancer Risk
Denmark - ovulation induction, used in the treatment of female infertility, would not affect cancer risk, according to a study conducted by Professor Jensen.

The study was conducted among 50,000 women with infertility problems to show the link between this type of treatment and cancer risk. By comparing the number of ovarian cancer in women who used to induce ovulation than women who had never taken the team of Prof. Jensen has found no additional risk to the first group women.

Infertility is often caused by a hormonal imbalance that disturbs the production of eggs on a regular basis. The ovulation-inducing drugs stimulate the ovaries to increase chances of ovulation. But this weakens the ovarian stimulation that cannot heal properly after egg production.

The study, however, must be refined with advancing age in women followed since age 60 is the age where occur most of the major cancers and that many women have not followed this age.

The inductions of ovulation are very effective and would be responsible for the increase in multiple pregnancies.

INFERTILITY DUE TO CHANGES IN REPRODUCTIVE ORGANS ?

|

Infertility Due To Changes In Reproductive Organs?
Israel - Dr Hasson of the University of Tel Aviv issued a new theory about the declining fertility of human couples. The evolution of reproductive organs would make sperm more aggressive face of ova more protectionist.

To Dr. Hasson, thousands of years of evolution have altered the complementarity of the reproductive organs of men and women. "The rate of human infertility is much higher than expected. At present, developments should have improved our success rate. Something else happens," says he.

For thousands of years, women's bodies has forced the sperm to be more competitive and therefore more aggressive. But this aggressiveness alters the blocking process that occurs when the egg is fertilized by one sperm.

The new force of sperm that the blocking process has no time to implement and a second sperm can enter the egg. The egg is then destroyed by the polyspermy and fertilization stopped.

"To avoid the fatal consequences of polyspermy, female reproductive tract has evolved to become a formidable barrier to sperm". This fuels an arms race "between the sexes that causes the decline of fertility," describes Dr. Hasson.

An estimated 10% of couples experiencing fertility problems. The lifestyle and environmental causes are often cited to justify this reduction.

IMPORTANT STEP TOWARDS CURE DIABETES THROUGH EMBRYONIC STEM CELLS


Important Step Towards Cure Diabetes Through Embryonic Stem Cells
American researchers have managed to make embryonic stem cells behave as cells of the pancreas can produce insulin. Published in the journal Nature Biotechnology, this study marks an important step in using stem cells to treat diabetes.

Treating diabetes is a promise based on embryonic stem cells, scientists are trying to actually find a formula to transform embryonic stem cells into pancreatic beta cells, these cells produce insulin in response to the presence of sugar in the blood, they are defective or absent in patients suffering from type 1 diabetes. This feat would allow patients to produce insulin again, but researchers have not succeeded so far.

However, Dr. Emmanuel Baetge and colleagues at the biotech company Novocell of San Diego (California) managed to make embryonic stem cells behave like pancreatic beta cells in mice. For years this group has indeed tried, using the same factors that induce pancreas development in the embryo, transform embryonic stem cells into pancreatic cells in a petridish. They had previously reported that they were able to obtain insulin-secreting cells but these cells do not respond to the presence of glucose, gold is an essential characteristic of pancreatic beta cells.

The researchers then stepped back and instead of trying to obtain mature pancreatic cells cultured in a petridish, they used cells "immature" still under development. These immature cells called the endoderm are equivalent to cells of the pancreas of an embryo aged 6 to 9 weeks. They transplanted these human stem cells that had not completed their development in a mouse, hoping the animal would produce the missing factors to complete the development of the organ. One month after transplantation the researchers were able to detect C-peptide of human origin (this protein is a derivative of insulin production). Two months after transplantation, the mice increased the production of human C-peptide response to glucose, demonstrating thsat the transplanted cells were indeed functional. Finally the researchers damaged beta cells of mice with a toxin. This treatment usually makes the diabetic mice, except that in this case the mouse does not become diabetic showing that the transplanted cells could replace pancreatic beta cells defective.

Other researchers working in this field readily acknowledge that this study is a breakthrough in the fight against diabetes. Dr. Baetge moreover said that the company Novocell was in contact with the U.S. Food and Drug Administration (the U.S. authority responsible for regulating food and drug) to determine what additional security tests were needed before proceeding clinical trials on humans.

Dr. Teresa Ku of the Beckman Research Institute in Duarte (California) who also works in this area recognizes that this work is very important in this research field. She said the best solution would be to achieve fully differentiated cells in a culture dish.

Source: ScienceNOW Daily News

Followers

My Favorite Links!